Illumina’s Billion Cell Atlas aims to standardize massive CRISPR perturbation data to make biological response patterns more ...
In this randomized controlled trial involving pediatric patients, fremanezumab led to greater reductions in the number of migraine days per month versus placebo, consistent with previous trials in ...
Injuries suffered at high elevations are associated with a significantly higher odds of developing deep vein thrombosis (DVT) ...
Anthropic is packaging Claude as a governed healthcare workflow tool aimed at documentation, prior authorization, and other ...
Duloxetine is significantly more effective than placebo at reducing refractory chronic cough (RCC) frequency and sensitivity.
AstraZeneca is acquiring Modella AI to embed multimodal foundation models into oncology R&D and strengthen biomarker driven ...
Lyme disease (LD) is associated with substantial health care costs, with per-patient direct costs consistently high across ...
NVIDIA and Lilly put $1B behind AI as core drug infrastructure During the JPMorgan Healthcare Conference week in mid January ...
NVIDIA and Eli Lilly plan to invest up to $1B over five years in a joint AI lab to tighten the loop between model building ...
In this cohort study, a novel prognostic model was developed to estimate prostate cancer-specific mortality (PCSM) while ...
In this systematic review, 17% of primary care patients were perceived as difficult by physicians, particularly those with ...
Ethosuximide was not superior to placebo for the treatment of abdominal pain in adults with irritable bowel syndrome. Evidence Rating Level: 1 (Excellent) Previous research suggested that increased ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results